MEU
Marmota Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Marmota Ltd. is a mining exploration company, It focuses on gold, copper, and uranium properties. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-11-21. The firm's projects include Gawler Craton, Copper Coast, Yorke Peninsula and Junction Dam. The Company’s copper project is based at the Melton project on the Yorke Peninsula. The firm's uranium project is at Junction Dam adjacent to the Honeymoon mine. The Gawler Craton gold project comprises around 6,000 square kilometers in the Woomera Prohibited Area. The company has been active on the Champion Prospect in the West Melton tenement (100% owned), on the Copper Coast of the Yorke Peninsula. Junction Dam is the Company’s flagship uranium project, located 50 kilometers (km) west of Broken Hill.
📈 Performance
Price History
-42.15%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.03
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MEU
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in MEU
494 days
MEU investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
Less than 50k
50%
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
50%
Male
50%
Pearlers who invest in MEU also invest in...
Oneview Healthcare Plc engages in the provision of interactive patient care. The principal activity of the Company is the development and sale of software for the healthcare sector and the provision of related consultancy services. The firm is engaged in providing a patient engagement solution for the healthcare sector. Its geographical areas include Ireland, the United States, Australia, Asia and the Middle East. Its solution includes empowering patients and families, managing patient experience, delivering virtual care, digital door sign and a patient communication board. The Company’s wholly owned subsidiaries include Oneview Limited, Oneview KSA Limited, Oneview Healthcare Inc, Oneview Assisted Living Inc, Oneview Middle East DMCC, Oneview Healthcare PTY Limited, Oneview Assisted Living PTY Limited and Oneview Healthcare Company Limited.
📊 Share price
$0.20 AUD
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
📊 Share price
$320.13 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)
📊 Share price
$74.40 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
Meridian Energy Ltd. engages in the generation and distribution of electricity from renewable resources. The firm is engaged in the business of generation, trading and retailing of electricity, and the sale of complementary products and services. The firm operates through three segments: Wholesale, Retail and International. The Wholesale segment includes activity associated with its New Zealand generation of electricity and its sale into the wholesale electricity market; purchase of electricity, and development of renewable electricity generation opportunities. The Retail segment includes activity associated with retailing of electricity and complementary products through its two brands: Meridian and Powershop in New Zealand. The International segment includes activity associated with its generation of electricity and sale into the wholesale electricity market and licensing of the Powershop platform in the United Kingdom. The firm supplies electricity to power homes, businesses and farms.
📊 Share price
$5.09 AUD
Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The firm is engaged in developing novel medical devices, diagnostics, and media with applications to assisted reproduction technology (ART) in humans and animals. Its reproductive biotechnology products in development include medical devices, in vitro diagnostics, and new proprietary media. The firm's product pipeline includes Felix, ROSA, and AI-Port. The Felix is a patented, automated device for quickly separating high quality sperm from semen for use in human in vitro fertilization (IVF) procedures without causing damage to DNA. Felix has a sizable target market worldwide. The Company’s ROSA is an in vitro diagnostic that assesses semen and blood samples for the presence of oxidative stress. The AI-Port stores and transports animal semen for artificial insemination (AI) for up to four days without the harmful effects of freezing sperm used in standard AI procedures in livestock.
📊 Share price